Signal transduction by tumor necrosis factor and its relatives

Tracey, 1993, Tumor necrosis factor, other cytokines and disease, Annu. Rev. Cell Biol., 9, 317, 10.1146/annurev.cb.09.110193.001533 Locksley, 2001, The TNF and TNF receptor superfamilies: integrating mammalian biology, Cell, 104, 487, 10.1016/S0092-8674(01)00237-9 Idriss, 2000, TNFα and the TNF receptor superfamily: structure–function relationship(s), Microsc. Res. Tech., 50, 184, 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H Ashkenazi, 1999, Apoptosis control by death and decoy receptors, Curr. Opin. Cell Biol., 11, 255, 10.1016/S0955-0674(99)80034-9 Tsubata, 1993, B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40, Nature, 364, 645, 10.1038/364645a0 Chang, 2000, Proteases for cell suicide: functions and regulation of caspases, Microbiol. Mol. Biol. Rev., 64, 821, 10.1128/MMBR.64.4.821-846.2000 Barnes, 1997, Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases, New Engl. J. Med., 336, 1066, 10.1056/NEJM199704103361506 Karin, 1997, AP-1 function and regulation, Curr. Opin. Cell Biol., 9, 240, 10.1016/S0955-0674(97)80068-3 Baldwin, 1996, The NF-κB and IκB proteins: new discoveries and insights, Annu. Rev. Immunol., 14, 649, 10.1146/annurev.immunol.14.1.649 Karin, 2000, Phosphorylation meets ubiquitination: the control of NF-κB activity, Annu. Rev. Immunol., 18, 621, 10.1146/annurev.immunol.18.1.621 Han, 1997, Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation, Nature, 386, 296, 10.1038/386296a0 Vandenabeele, 1995, Two tumor necrosis factor receptors: structure and function, Trends Cell Biol., 5, 392, 10.1016/S0962-8924(00)89088-1 Hsu, 1996, TRADD–TRAF2 and TRADD–FADD interactions define two distinct TNF receptor 1 signal transduction pathways, Cell, 84, 299, 10.1016/S0092-8674(00)80984-8 Rothe, 1994, A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor, Cell, 78, 681, 10.1016/0092-8674(94)90532-0 Rothe, 1995, TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40, Science, 269, 1424, 10.1126/science.7544915 Stanger, 1995, RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death, Cell, 81, 513, 10.1016/0092-8674(95)90072-1 Chinnaiyan, 1995, FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis, Cell, 81, 505, 10.1016/0092-8674(95)90071-3 Arch, 1998, Tumor necrosis factor receptor-associated factors (TRAFs) – a family of adapter proteins that regulates life and death, Genes Dev., 12, 2821, 10.1101/gad.12.18.2821 Park, 2000, A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD–TRAF2 interaction, Cell, 101, 777, 10.1016/S0092-8674(00)80889-2 Liu, 1996, Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death, Cell, 87, 565, 10.1016/S0092-8674(00)81375-6 Song, 1997, Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2, Proc. Natl. Acad. Sci. U. S. A., 94, 9792, 10.1073/pnas.94.18.9792 Baud, 1999, Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain, Genes Dev., 13, 1297, 10.1101/gad.13.10.1297 Park, 1999, Structural basis for self-association and receptor recognition of human TRAF2, Nature, 398, 533, 10.1038/19110 Ting, 1996, RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis, EMBO J., 15, 6189, 10.1002/j.1460-2075.1996.tb01007.x Yu, 1999, Identification of RIP3, a RIP-like kinase that activates apoptosis and NF-κB, Curr. Biol., 9, 539, 10.1016/S0960-9822(99)80239-5 McCarthy, 1998, RIP2 is a novel NF-κB-activating and cell death-inducing kinase, J. Biol. Chem., 273, 16968, 10.1074/jbc.273.27.16968 Kelliher, 1998, The death domain kinase RIP mediates the TNF-induced NF-κB signal, Immunity, 8, 297, 10.1016/S1074-7613(00)80535-X Devin, 2000, The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation, Immunity, 12, 419, 10.1016/S1074-7613(00)80194-6 Lee, 1997, TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival, Immunity, 7, 703, 10.1016/S1074-7613(00)80390-8 Nakano, 2000, Impaired TNF-induced NF-κB activation and high sensitivity to TNF-induced cell death in TRAF2- and TRAF5-double deficient mice, Scand. J. Immunol., 51, 71 Nagata, 1999, Fas ligand-induced apoptosis, Annu. Rev. Genet., 33, 29, 10.1146/annurev.genet.33.1.29 Yeh, 1998, FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis, Science, 279, 1954, 10.1126/science.279.5358.1954 Natoli, 1997, Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway, Science, 275, 200, 10.1126/science.275.5297.200 Nishitoh, 1998, ASK1 is essential for JNK/SAPK activation by TRAF2, Mol. Cell, 2, 389, 10.1016/S1097-2765(00)80283-X Yuasa, 1998, Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38, J. Biol. Chem., 273, 22681, 10.1074/jbc.273.35.22681 Minden, 1994, Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK, Science, 266, 1719, 10.1126/science.7992057 Xia, 1998, JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension, Genes Dev., 12, 3369, 10.1101/gad.12.21.3369 Lee, 1997, Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway, Cell, 88, 213, 10.1016/S0092-8674(00)81842-5 Karin, 1998, JNK or IKK, AP-1 or NF-κB, which are the targets for MEKK1 action?, Proc. Natl. Acad. Sci. U. S. A., 95, 9067, 10.1073/pnas.95.16.9067 Xia, 2000, MEKK1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration, Proc. Natl. Acad. Sci. U. S. A., 97, 5243, 10.1073/pnas.97.10.5243 Yujiri, 2000, MEKK1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-κB activation, Proc. Natl. Acad. Sci. U. S. A., 97, 7272, 10.1073/pnas.130176697 Tobiume, 2001, ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis, EMBO Rep., 2, 222, 10.1093/embo-reports/kve046 Ichijo, 1997, Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways, Science, 275, 90, 10.1126/science.275.5296.90 Tournier, 2000, Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway, Science, 288, 870, 10.1126/science.288.5467.870 Kirillova, 1999, Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor-κB activation, Cell Growth Differ., 10, 819 Delhase, 1999, Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation, Science, 284, 309, 10.1126/science.284.5412.309 Malinin, 1997, MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1, Nature, 385, 540, 10.1038/385540a0 Woronicz, 1997, IκB kinase β: NF-κB activation and complex formation with IκB kinase α and NIK, Science, 278, 866, 10.1126/science.278.5339.866 Ling, 1998, NF-κB-inducing kinase activates IKKα by phosphorylation of Ser-176, Proc. Natl. Acad. Sci. U. S. A., 95, 3792, 10.1073/pnas.95.7.3792 Hu, 1999, Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase, Science, 284, 316, 10.1126/science.284.5412.316 Yin, 2001, Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice, Science, 291, 2162, 10.1126/science.1058453 Shinkura, 1999, Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase, Nat. Genet., 22, 74, 10.1038/8780 Xiao, 2001, NF-κB-inducing kinase regulates the processing of NF-κB2 p100, Mol. Cell, 7, 401, 10.1016/S1097-2765(01)00187-3 Caamano, 1998, Nuclear factor NF-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses, J. Exp. Med., 187, 185, 10.1084/jem.187.2.185 Lee, 1998, MEKK1 activates both IκB kinase α and IκB kinase β, Proc. Natl. Acad. Sci. U. S. A., 95, 9319, 10.1073/pnas.95.16.9319 Zhao, 1999, Regulation of the MEF2 family of transcription factors by p38, Mol. Cell. Biol., 19, 21, 10.1128/MCB.19.1.21 Lin, 1999, The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases, Immunity, 10, 271, 10.1016/S1074-7613(00)80027-8 Ozes, 1999, NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase, Nature, 401, 82, 10.1038/43466 Ninomiya-Tsuji, 1999, The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway, Nature, 398, 252, 10.1038/18465 Zhang, 2000, Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO/IKKγ upon receptor stimulation, Immunity, 12, 301, 10.1016/S1074-7613(00)80183-1 Vig, 1999, Modulation of tumor necrosis factor and interleukin-1-dependent NF-κB activity by mPLK/IRAK, J. Biol. Chem., 274, 13077, 10.1074/jbc.274.19.13077 Deng, 2000, Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain, Cell, 103, 351, 10.1016/S0092-8674(00)00126-4 Madrid, 2001, Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κB through utilization of the IκB kinase and activation of the mitogen activated protein kinase p38, J. Biol. Chem., 276, 18934, 10.1074/jbc.M101103200 Delhase, 2000, Kinase regulation in inflammatory response, Nature, 406, 367, 10.1038/35019154 Hoeflich, 2000, Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation, Nature, 406, 86, 10.1038/35017574 Sanz, 1999, The interaction of p62 with RIP links the atypical PKCs to NF-κB activation, EMBO J., 18, 3044, 10.1093/emboj/18.11.3044 Vadlamudi, 1996, p62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins, J. Biol. Chem., 271, 20235, 10.1074/jbc.271.34.20235 Rath, 1999, TNF-induced signaling in apoptosis, J. Clin. Immunol., 19, 350, 10.1023/A:1020546615229 Varfolomeev, 1998, Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally, Immunity, 9, 267, 10.1016/S1074-7613(00)80609-3 Earnshaw, 1999, Mammalian caspases: structure, activation, substrates, and functions during apoptosis, Annu. Rev. Biochem., 68, 383, 10.1146/annurev.biochem.68.1.383 Deveraux, 1999, IAP family proteins – suppressors of apoptosis, Genes Dev., 13, 239, 10.1101/gad.13.3.239 Balkwill, 2000, TNF is here to stay!, Immunol. Today, 21, 470, 10.1016/S0167-5699(00)01722-9 Galon, 2000, TNFRSF1A mutations and autoinflammatory syndromes, Curr. Opin. Immunol., 12, 479, 10.1016/S0952-7915(00)00124-2 Jones, 1999, Tumor necrosis factor inhibitors for rheumatoid arthritis, Bull. Rheum. Dis., 48, 1 Bell, 2000, Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease, Lancet, 355, 858, 10.1016/S0140-6736(99)00442-0